Renovaro Inc. - Common Stock (NQ: RENB )
0.9700
+0.0527
(+5.75%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Press Releases about Renovaro Inc. - Common StockVia GlobeNewswire
Patients with Swelling Disorder See New Gene Therapy as Godsend
February 07, 2024
Via GlobeNewswire
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message
January 16, 2024
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Study Shows Ongoing Benefits Once Immunotherapy Stops
January 02, 2024
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|